{"count": 28, "results": [{"_id": "31924353", "pmid": 31924353, "title": "Simvastatin down-regulates osteogenic response in cultured human aortic valve interstitial cells.", "journal": "J Thorac Cardiovasc Surg", "authors": ["Jarrett MJ", "Yao Q", "Venardos N", "Weyant MJ", "Reece TB", "Meng X", "Fullerton DA"], "date": "2021-04-01T00:00:00Z", "doi": "10.1016/j.jtcvs.2019.10.081", "meta_date_publication": "2021 Apr", "meta_volume": "161", "meta_issue": "4", "meta_pages": "e261-e271", "score": 50258.51, "text_hl": "These data offer mechanistic insight into a possible therapeutic role for @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in the prevention of @<m>DISEASE_Aortic_Valve_Stenosis</m> @DISEASE_MESH:D001024 @@@aortic stenosis@@@.", "citations": {"NLM": "Jarrett MJ, Yao Q, Venardos N, Weyant MJ, Reece TB, Meng X, Fullerton DA. Simvastatin down-regulates osteogenic response in cultured human aortic valve interstitial cells. J Thorac Cardiovasc Surg. 2021 Apr;161(4):e261-e271. PMID: 31924353", "BibTeX": "@article{31924353, title={Simvastatin down-regulates osteogenic response in cultured human aortic valve interstitial cells.}, author={Jarrett MJ and Yao Q and Venardos N and Weyant MJ and Reece TB and Meng X and Fullerton DA}, journal={J Thorac Cardiovasc Surg}, volume={161}, number={4}, pages={e261-e271}}"}}, {"_id": "35171199", "pmid": 35171199, "title": "Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements With Clinical Events in Patients With Asymptomatic Nonsevere Aortic Stenosis: A Post Hoc Substudy of the SEAS Trial.", "journal": "JAMA Cardiol", "authors": ["Hadziselimovic E", "Greve AM", "Sajadieh A", "Olsen MH", "Kesäniemi YA", "Nienaber CA", "Ray SG", "Rossebø AB", "Willenheimer R", "Wachtell K", "Nielsen OW"], "date": "2022-04-01T00:00:00Z", "doi": "10.1001/jamacardio.2021.5916", "meta_date_publication": "2022 Apr 1", "meta_volume": "7", "meta_issue": "4", "meta_pages": "435-444", "score": 50238.957, "text_hl": "DESIGN, SETTING, AND PARTICIPANTS: Analysis of annual NT-proBNP concentrations in the multicenter, double-blind @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ and @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@Ezetimibe@@@ in @<m>DISEASE_Aortic_Valve_Stenosis</m> @DISEASE_MESH:D001024 @@@Aortic Stenosis@@@ (SEAS) randomized clinical trial was performed. ", "citations": {"NLM": "Hadziselimovic E, Greve AM, Sajadieh A, Olsen MH, Kesäniemi YA, Nienaber CA, Ray SG, Rossebø AB, Willenheimer R, Wachtell K, Nielsen OW. Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements With Clinical Events in Patients With Asymptomatic Nonsevere Aortic Stenosis: A Post Hoc Substudy of the SEAS Trial. JAMA Cardiol. 2022 Apr 1;7(4):435-444. PMID: 35171199", "BibTeX": "@article{35171199, title={Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements With Clinical Events in Patients With Asymptomatic Nonsevere Aortic Stenosis: A Post Hoc Substudy of the SEAS Trial.}, author={Hadziselimovic E and Greve AM and Sajadieh A and Olsen MH and Kesäniemi YA and Nienaber CA and Ray SG and Rossebø AB and Willenheimer R and Wachtell K and Nielsen OW}, journal={JAMA Cardiol}, volume={7}, number={4}, pages={435-444}}"}}, {"_id": "18765433", "pmid": 18765433, "title": "Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.", "journal": "N Engl J Med", "authors": ["Rossebø AB", "Pedersen TR", "Boman K", "Brudi P", "Chambers JB", "Egstrup K", "Gerdts E", "Gohlke-Bärwolf C", "Holme I", "Kesäniemi YA", "Malbecq W", "Nienaber CA", "Ray S", "Skjaerpe T", "Wachtell K", "Willenheimer R", "SEAS Investigators"], "date": "2008-09-25T00:00:00Z", "doi": "10.1056/NEJMoa0804602", "meta_date_publication": "2008 Sep 25", "meta_volume": "359", "meta_issue": "13", "meta_pages": "1343-56", "score": 50071.453, "text_hl": "Intensive @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ lowering with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ in @<m>DISEASE_Aortic_Valve_Stenosis</m> @DISEASE_MESH:D001024 @@@aortic stenosis@@@.", "citations": {"NLM": "Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R, SEAS Investigators. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008 Sep 25;359(13):1343-56. PMID: 18765433", "BibTeX": "@article{18765433, title={Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.}, author={Rossebø AB and Pedersen TR and Boman K and Brudi P and Chambers JB and Egstrup K and Gerdts E and Gohlke-Bärwolf C and Holme I and Kesäniemi YA and Malbecq W and Nienaber CA and Ray S and Skjaerpe T and Wachtell K and Willenheimer R and SEAS Investigators}, journal={N Engl J Med}, volume={359}, number={13}, pages={1343-56}}"}}, {"_id": "17398194", "pmid": 17398194, "title": "Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.", "journal": "Am J Cardiol", "authors": ["Rossebø AB", "Pedersen TR", "Allen C", "Boman K", "Chambers J", "Egstrup K", "Gerdts E", "Gohlke-Bärwolf C", "Holme I", "Kesäniemi VA", "Malbecq W", "Nienaber C", "Ray S", "Skjaerpe T", "Wachtell K", "Willenheimer R"], "date": "2007-04-01T00:00:00Z", "doi": "10.1016/j.amjcard.2006.10.064", "meta_date_publication": "2007 Apr 1", "meta_volume": "99", "meta_issue": "7", "meta_pages": "970-3", "score": 50070.57, "text_hl": "Design and baseline characteristics of the @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ in @<m>DISEASE_Aortic_Valve_Stenosis</m> @DISEASE_MESH:D001024 @@@aortic stenosis@@@ (SEAS) study.", "citations": {"NLM": "Rossebø AB, Pedersen TR, Allen C, Boman K, Chambers J, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi VA, Malbecq W, Nienaber C, Ray S, Skjaerpe T, Wachtell K, Willenheimer R. Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. Am J Cardiol. 2007 Apr 1;99(7):970-3. PMID: 17398194", "BibTeX": "@article{17398194, title={Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.}, author={Rossebø AB and Pedersen TR and Allen C and Boman K and Chambers J and Egstrup K and Gerdts E and Gohlke-Bärwolf C and Holme I and Kesäniemi VA and Malbecq W and Nienaber C and Ray S and Skjaerpe T and Wachtell K and Willenheimer R}, journal={Am J Cardiol}, volume={99}, number={7}, pages={970-3}}"}}, {"_id": "10452122", "pmid": 10452122, "title": "Effects of simvastatin on left ventricular hypertrophy and function in rats with aortic stenosis.", "journal": "Zhongguo Yao Li Xue Bao", "authors": ["Luo JD", "Zhang WW", "Zhang GP", "Liu XH", "Guan JX"], "date": "1999-04-01T00:00:00Z", "meta_date_publication": "1999 Apr", "meta_volume": "20", "meta_issue": "4", "meta_pages": "345-8", "score": 50068.504, "text_hl": "Effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @DISEASE_Hypertrophy_Left_Ventricular @DISEASE_MESH:D017379 @@@left ventricular hypertrophy@@@ and function in @SPECIES_10116 @@@rats@@@ with @<m>DISEASE_Aortic_Valve_Stenosis</m> @DISEASE_MESH:D001024 @@@aortic stenosis@@@.", "citations": {"NLM": "Luo JD, Zhang WW, Zhang GP, Liu XH, Guan JX. Effects of simvastatin on left ventricular hypertrophy and function in rats with aortic stenosis. Zhongguo Yao Li Xue Bao. 1999 Apr;20(4):345-8. PMID: 10452122", "BibTeX": "@article{10452122, title={Effects of simvastatin on left ventricular hypertrophy and function in rats with aortic stenosis.}, author={Luo JD and Zhang WW and Zhang GP and Liu XH and Guan JX}, journal={Zhongguo Yao Li Xue Bao}, volume={20}, number={4}, pages={345-8}}"}}, {"_id": "19228479", "pmid": 19228479, "title": "Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis (the SEAS trial).", "journal": "Curr Atheroscler Rep", "authors": ["Farmer JA"], "date": "2009-03-01T00:00:00Z", "meta_date_publication": "2009 Mar", "meta_volume": "11", "meta_issue": "2", "meta_pages": "82-3", "score": 50067.395, "text_hl": "Intensive @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ lowering with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ in @<m>DISEASE_Aortic_Valve_Stenosis</m> @DISEASE_MESH:D001024 @@@aortic stenosis@@@ (the SEAS trial).", "citations": {"NLM": "Farmer JA. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis (the SEAS trial). Curr Atheroscler Rep. 2009 Mar;11(2):82-3. PMID: 19228479", "BibTeX": "@article{19228479, title={Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis (the SEAS trial).}, author={Farmer JA}, journal={Curr Atheroscler Rep}, volume={11}, number={2}, pages={82-3}}"}}, {"_id": "29602140", "pmid": 29602140, "title": "Effect of simvastatin and ezetimibe on suPAR levels and outcomes.", "journal": "Atherosclerosis", "authors": ["Hodges GW", "Bang CN", "Forman JL", "Olsen MH", "Boman K", "Ray S", "Kesäniemi YA", "Eugen-Olsen J", "Greve AM", "Jeppesen JL", "Wachtell K"], "date": "2018-05-01T00:00:00Z", "doi": "10.1016/j.atherosclerosis.2018.03.030", "meta_date_publication": "2018 May", "meta_volume": "272", "meta_issue": "", "meta_pages": "129-136", "score": 50065.25, "text_hl": "METHODS: We investigated whether treatment with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ 40 mg and @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@Ezetimibe@@@ 10 mg lowered plasma suPAR levels in 1838 @SPECIES_9606 @@@patients@@@ with mild-moderate, asymptomatic @<m>DISEASE_Aortic_Valve_Stenosis</m> @DISEASE_MESH:D001024 @@@aortic stenosis@@@, included in the @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ and @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@Ezetimibe@@@ in @<m>DISEASE_Aortic_Valve_Stenosis</m> @DISEASE_MESH:D001024 @@@Aortic Stenosis@@@ (SEAS) study, using a pattern mixture model. ", "citations": {"NLM": "Hodges GW, Bang CN, Forman JL, Olsen MH, Boman K, Ray S, Kesäniemi YA, Eugen-Olsen J, Greve AM, Jeppesen JL, Wachtell K. Effect of simvastatin and ezetimibe on suPAR levels and outcomes. Atherosclerosis. 2018 May;272():129-136. PMID: 29602140", "BibTeX": "@article{29602140, title={Effect of simvastatin and ezetimibe on suPAR levels and outcomes.}, author={Hodges GW and Bang CN and Forman JL and Olsen MH and Boman K and Ray S and Kesäniemi YA and Eugen-Olsen J and Greve AM and Jeppesen JL and Wachtell K}, journal={Atherosclerosis}, volume={272}, pages={129-136}}"}}, {"_id": "18095904", "pmid": 18095904, "title": "Ezetimibe plus simvastatin cardiovascular outcomes study program.", "journal": "Expert Rev Cardiovasc Ther", "authors": ["Padial LR"], "date": "2008-01-01T00:00:00Z", "doi": "10.1586/14779072.6.1.17", "meta_date_publication": "2008 Jan", "meta_volume": "6", "meta_issue": "1", "meta_pages": "17-25", "score": 50063.07, "text_hl": "Four major outcome trials are underway to study the effect of @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ plus @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in different subsets of high-risk @SPECIES_9606 @@@patients@@@: familiar @DISEASE_Hypercholesterolemia @DISEASE_MESH:D006937 @@@hypercholesterolemia@@@, @<m>DISEASE_Aortic_Valve_Stenosis</m> @DISEASE_MESH:D001024 @@@degenerative aortic stenosis@@@, @DISEASE_Renal_Insufficiency_Chronic @DISEASE_MESH:D051436 @@@chronic kidney disease@@@ and @DISEASE_Acute_Coronary_Syndrome @DISEASE_MESH:D054058 @@@acute coronary syndrome@@@. ", "citations": {"NLM": "Padial LR. Ezetimibe plus simvastatin cardiovascular outcomes study program. Expert Rev Cardiovasc Ther. 2008 Jan;6(1):17-25. PMID: 18095904", "BibTeX": "@article{18095904, title={Ezetimibe plus simvastatin cardiovascular outcomes study program.}, author={Padial LR}, journal={Expert Rev Cardiovasc Ther}, volume={6}, number={1}, pages={17-25}}"}}, {"_id": "23416018", "pmid": 23416018, "title": "Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study.", "journal": "Int J Cardiol", "authors": ["Bang CN", "Dalsgaard M", "Greve AM", "Køber L", "Gohlke-Baerwolf C", "Ray S", "Rossebø AB", "Egstrup K", "Wachtell K"], "date": "2013-10-03T00:00:00Z", "doi": "10.1016/j.ijcard.2013.01.060", "meta_date_publication": "2013 Oct 3", "meta_volume": "168", "meta_issue": "3", "meta_pages": "2322-7", "score": 50063.023, "text_hl": "Left atrial size and function as predictors of new-onset of @DISEASE_Atrial_Fibrillation @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ in @SPECIES_9606 @@@patients@@@ with asymptomatic @<m>DISEASE_Aortic_Valve_Stenosis</m> @DISEASE_MESH:D001024 @@@aortic stenosis@@@: the @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ in @<m>DISEASE_Aortic_Valve_Stenosis</m> @DISEASE_MESH:D001024 @@@aortic stenosis@@@ study.", "citations": {"NLM": "Bang CN, Dalsgaard M, Greve AM, Køber L, Gohlke-Baerwolf C, Ray S, Rossebø AB, Egstrup K, Wachtell K. Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study. Int J Cardiol. 2013 Oct 3;168(3):2322-7. PMID: 23416018", "BibTeX": "@article{23416018, title={Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study.}, author={Bang CN and Dalsgaard M and Greve AM and Køber L and Gohlke-Baerwolf C and Ray S and Rossebø AB and Egstrup K and Wachtell K}, journal={Int J Cardiol}, volume={168}, number={3}, pages={2322-7}}"}}, {"_id": "10561812", "pmid": 10561812, "title": "Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis.", "journal": "Clin Exp Pharmacol Physiol", "authors": ["Luo JD", "Zhang WW", "Zhang GP", "Guan JX", "Chen X"], "date": "1999-11-01T00:00:00Z", "doi": "10.1046/j.1440-1681.1999.03165.x", "meta_date_publication": "1999 Nov", "meta_volume": "26", "meta_issue": "11", "meta_pages": "903-8", "score": 50061.777, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ inhibits @DISEASE_Cardiomegaly @DISEASE_MESH:D006332 @@@cardiac hypertrophy@@@ and @GENE_ACE @GENE_24310 @@@angiotensin-converting enzyme@@@ activity in @SPECIES_10116 @@@rats@@@ with @<m>DISEASE_Aortic_Valve_Stenosis</m> @DISEASE_MESH:D001024 @@@aortic stenosis@@@.", "citations": {"NLM": "Luo JD, Zhang WW, Zhang GP, Guan JX, Chen X. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis. Clin Exp Pharmacol Physiol. 1999 Nov;26(11):903-8. PMID: 10561812", "BibTeX": "@article{10561812, title={Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis.}, author={Luo JD and Zhang WW and Zhang GP and Guan JX and Chen X}, journal={Clin Exp Pharmacol Physiol}, volume={26}, number={11}, pages={903-8}}"}}]}